| 000 | 02445 a2200745 4500 | ||
|---|---|---|---|
| 005 | 20250517024745.0 | ||
| 264 | 0 | _c20160120 | |
| 008 | 201601s 0 0 eng d | ||
| 022 | _a2219-2840 | ||
| 024 | 7 |
_a10.3748/wjg.v21.i13.4006 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhang, Yuan-Yuan | |
| 245 | 0 | 0 |
_aInterferon-λ-related genes and therapeutic response in Chinese hepatitis C patients. _h[electronic resource] |
| 260 |
_bWorld journal of gastroenterology _cApr 2015 |
||
| 300 |
_a4006-13 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 |
_aAsian People _xgenetics |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aChi-Square Distribution |
| 650 | 0 | 4 |
_aChina _xepidemiology |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Frequency |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHepacivirus _xdrug effects |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xdiagnosis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterferon alpha-2 |
| 650 | 0 | 4 |
_aInterferon-alpha _xtherapeutic use |
| 650 | 0 | 4 | _aInterferons |
| 650 | 0 | 4 |
_aInterleukin-10 Receptor beta Subunit _xgenetics |
| 650 | 0 | 4 |
_aInterleukins _xgenetics |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 | _aLogistic Models |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 |
_aMyxovirus Resistance Proteins _xgenetics |
| 650 | 0 | 4 | _aOdds Ratio |
| 650 | 0 | 4 | _aPharmacogenetics |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 |
_aPolyethylene Glycols _xtherapeutic use |
| 650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 |
_aRNA, Viral _xblood |
| 650 | 0 | 4 | _aROC Curve |
| 650 | 0 | 4 |
_aReceptors, Cytokine _xgenetics |
| 650 | 0 | 4 | _aReceptors, Interferon |
| 650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
| 650 | 0 | 4 |
_aRibavirin _xtherapeutic use |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aViral Load |
| 700 | 1 | _aChen, Hong-Bo | |
| 700 | 1 | _aXu, Yin | |
| 700 | 1 | _aHuang, Peng | |
| 700 | 1 | _aWang, Jie | |
| 700 | 1 | _aZhang, Yun | |
| 700 | 1 | _aYu, Rong-Bin | |
| 700 | 1 | _aSu, Jing | |
| 773 | 0 |
_tWorld journal of gastroenterology _gvol. 21 _gno. 13 _gp. 4006-13 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3748/wjg.v21.i13.4006 _zAvailable from publisher's website |
| 999 |
_c24783648 _d24783648 |
||